Palliative treatment of advanced symptomatic prostate cancer.
Pregnancy and lactiation implications
Should not be used in women.
Unlabeled use
Contraindications
Hypersensitivity to abarelix or any ingredient in the formulation. Not indicated in women or pediatric patients.
Warnings and precautions
Risk of allergic reactions. May cause fetal harm. Increases in serum AST (SGOT) or ALT (SGPT) concentrations. Prolongation of QTc interval. Risk of decreased bone mineral density following chronic therapy with GnRH antagonists and agonists.